nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Challenging Case of Central Nervous System (CNS) Involvement with Chronic Lymphocytic Leukaemia (CLL): A Case Report
|
Alshamali, Sara Ali |
|
|
59 |
C |
p. |
artikel |
2 |
A Child with Intractable Vomiting: Brainstem Mass or Neuromyelitis Optica Spectrum Disorder
|
Mehdipour, Roshanak |
|
|
59 |
C |
p. |
artikel |
3 |
A comprehensive review of varicella-zoster virus, herpes simplex virus and cryptococcal infections associated with sphingosine-1-phosphate receptor modulators in multiple sclerosis patients
|
Sharma, Kanika |
|
|
59 |
C |
p. |
artikel |
4 |
Adrenoleukodystrophy in Adults: About a Case
|
Hakim, Si Ahmed |
|
|
59 |
C |
p. |
artikel |
5 |
Analysis of Visual Acuity, Contrast Sensitivity and Color Perception in Multiple Sclerosis Patients
|
Oreja-Guevara, Celia |
|
|
59 |
C |
p. |
artikel |
6 |
A national, multi-center study in Germany to assess implementation of infusion management, treatment satisfaction and quality of life in MS patients receiving alemtuzumab
|
Räuber, Saskia |
|
|
59 |
C |
p. |
artikel |
7 |
A Nationwide Pharmaco Epidemiological Study of Multiple Sclerosis in Greece
|
Bakirtzis, Christos |
|
|
59 |
C |
p. |
artikel |
8 |
An exploratory study regarding communication facilitators and barriers reported by a cohort of multiple sclerosis (MS) community members from the international massive open online course ‘Understanding MS’
|
Campbell, Julie A. |
|
|
59 |
C |
p. |
artikel |
9 |
A novel disease specific scale to characterize the symptoms and impacts of fatigue in US adults with relapsing multiple sclerosis: A real-world study
|
Azoulai, Marion |
|
|
59 |
C |
p. |
artikel |
10 |
Anti-Inflammatory Compounds Ameliorate Locomotion and Anxiety Behaviors in Cuprizone Mouse Model of Multiple Sclerosis
|
Alderbi, Rasha Mohammed |
|
|
59 |
C |
p. |
artikel |
11 |
Anxiety in Patients with Multiple Sclerosis
|
Bader, Sondes |
|
|
59 |
C |
p. |
artikel |
12 |
Artificial intelligence in the diagnosis of multiple sclerosis: A systematic review
|
Nabizadeh, Fardin |
|
|
59 |
C |
p. |
artikel |
13 |
Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients
|
Saraste, Maija |
|
|
59 |
C |
p. |
artikel |
14 |
Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study
|
Sedaghat, Nahad |
|
|
59 |
C |
p. |
artikel |
15 |
Association of Multiple Sclerosis and COVID-19 Infection: A Case Report
|
Ismail, Ismail Ibrahim |
|
|
59 |
C |
p. |
artikel |
16 |
Association of personality traits with physical function, cognition, and mood in multiple sclerosis
|
Kever, Anne |
|
|
59 |
C |
p. |
artikel |
17 |
Challenges of MS Patients for Receiving Health Care Services
|
Eskandarieh, Sharareh |
|
|
59 |
C |
p. |
artikel |
18 |
Chitinase-3 Like-Protein-1 in CSF: A Novel Biomarker for Progression in Multiple Sclerosis Patients
|
Dahshan, Ahmed |
|
|
59 |
C |
p. |
artikel |
19 |
Claims-Based Relapse and Hospitalization Rates in Patients with Multiple Sclerosis Treated with Natalizumab or Ocrelizumab
|
Nicholas, Jacqueline |
|
|
59 |
C |
p. |
artikel |
20 |
Clinical Characteristics of Switching Between Disease Modifying Drugs Among a Sample of Egyptian Multiple Sclerosis Patients
|
Eissa, Asmaa |
|
|
59 |
C |
p. |
artikel |
21 |
Clinical characteristics, sero- prevalence, treatment and outcomes of AQP4 IgG associated neuromyelits optic spectrum disorder (NMOSD) in Sri Lanka
|
Senanayake, Bimsara |
|
|
59 |
C |
p. |
artikel |
22 |
Clinical, Evolutionary and Etiological Particularities of Inflammatory Optic Neuropathies: An Algerian Population
|
Islam, Kediha Mohamed |
|
|
59 |
C |
p. |
artikel |
23 |
Cognitive Dual Tasking Impacts Lower Limbs Inter-Segmental Coordination During Walking in Patients with Multiple Sclerosis
|
Mofateh, Razieh |
|
|
59 |
C |
p. |
artikel |
24 |
Cognitive function in pediatric-onset relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)
|
Fabri, Tracy L |
|
|
59 |
C |
p. |
artikel |
25 |
Cognitive Impairment in Neuromyelitis Optica Spectrum Disorder and Brain Parenchyma Volume by Transcranial Sonography
|
Magdy, Rehab |
|
|
59 |
C |
p. |
artikel |
26 |
Comorbidity in multiple sclerosis: Emphasis on patient-reported outcomes
|
Diržiuvienė, Birutė |
|
|
59 |
C |
p. |
artikel |
27 |
Comparison of Time to Clinically Meaningful Improvement in Neuro-QOL in Patients Treated with Natalizumab Versus Ocrelizumab
|
Hersh, Carrie M. |
|
|
59 |
C |
p. |
artikel |
28 |
Contribution of relapse-associated worsening to overall disability accrual in patients with relapsing-onset multiple sclerosis: A mediation analysis
|
Chen, Bo |
|
|
59 |
C |
p. |
artikel |
29 |
COVID19 in Multiple Sclerosis Patients in Dubai: Observational Study
|
Thakre, Mona |
|
|
59 |
C |
p. |
artikel |
30 |
COVID-19 Vaccination in People with Multiple Sclerosis. the Kuwait Experience
|
Alroughani, Raed |
|
|
59 |
C |
p. |
artikel |
31 |
Demographic and Clinical Characteristics of Patients with Benign MS in Compare with Non-Benign MS
|
Moghadam, Nahid Beladi |
|
|
59 |
C |
p. |
artikel |
32 |
Demographic and Clinical Characteristics of Progressive Multiple Sclerosis: Findings from a Tunisian Cohort Study
|
Mrabet, Saloua |
|
|
59 |
C |
p. |
artikel |
33 |
Depression, Anxiety and Alexithymia in Tunisian Patients with Multiple Sclerosis
|
Mrabet, Saloua |
|
|
59 |
C |
p. |
artikel |
34 |
Depression in Multiple Sclerosis
|
Bader, Sondes |
|
|
59 |
C |
p. |
artikel |
35 |
Dialectical behavior therapy skills training for individuals with multiple sclerosis and their support partners: A pilot randomized controlled trial
|
Hughes, Abbey J. |
|
|
59 |
C |
p. |
artikel |
36 |
Distribution and relation of two arm function tests, Box and Blocks test and Nine Hole Peg test, across disease severity levels and types of multiple sclerosis
|
Bertoni, Rita |
|
|
59 |
C |
p. |
artikel |
37 |
Does Multiple Sclerosis Change Lower Limbs Inter-Segmental Coordination During Walking?
|
Mofateh, Razieh |
|
|
59 |
C |
p. |
artikel |
38 |
Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis
|
Sainz de la Maza, Susana |
|
|
59 |
C |
p. |
artikel |
39 |
Economic Analysis for Introduction of Cladribine Tablets as a Treatment for Relapsing Multiple Sclerosis Patients with High Disease Activity in Kuwait
|
Alroughani, Raed |
|
|
59 |
C |
p. |
artikel |
40 |
Effect of different initial rituximab regimens on B cell depletion in children with autoimmune neurological diseases
|
Zhang, Enyao |
|
|
59 |
C |
p. |
artikel |
41 |
Effects of Cognitive and Motor Secondary Tasks on Gait Performance in Healthy Controls and Multiple Sclerosis Patients with and Without Fall History
|
Mofateh, Razieh |
|
|
59 |
C |
p. |
artikel |
42 |
Effects of repetitive transcranial magnetic stimulation in multiple sclerosis: A systematic review and meta-analysis
|
Chen, Xiao |
|
|
59 |
C |
p. |
artikel |
43 |
Emotional processing intervention (EMOPRINT): A blinded randomized control trial to treat facial affect recognition deficits in multiple sclerosis
|
Genova, Helen M. |
|
|
59 |
C |
p. |
artikel |
44 |
Epidemiology of COVID-19 in Patients with MS: A Hospital-Based Registry
|
Eskandarieh, Sharareh |
|
|
59 |
C |
p. |
artikel |
45 |
Epidemiology of Multiple Sclerosis in Iraq: Retrospective Review of 4355 Cases and Literature Review
|
Hassoun, Hayder K |
|
|
59 |
C |
p. |
artikel |
46 |
Epidemiology of multiple sclerosis in West bank of Palestine
|
Abuawad, M. |
|
|
59 |
C |
p. |
artikel |
47 |
Evaluation of Anti-JVC Antibody Index Evolution in Patients with Multiple Sclerosis
|
Atrous, Amal |
|
|
59 |
C |
p. |
artikel |
48 |
Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets
|
Yamout, Bassem I |
|
|
59 |
C |
p. |
artikel |
49 |
Extended B-cell depletion beyond 6-months in patients receiving ocrelizumab or rituximab for CNS demyelinating disease
|
AbdelRazek, Mahmoud A. |
|
|
59 |
C |
p. |
artikel |
50 |
Familial MS in the South Caspian Sea
|
Baghbanian, Seyedmohammad |
|
|
59 |
C |
p. |
artikel |
51 |
First Study in Iraq About (HLA)-Drb1 * 15:01 as a Genetic Risk Factor for MS Initiation
|
Khaliel, Alaa Hassan |
|
|
59 |
C |
p. |
artikel |
52 |
Gender Based Epidemiologic Survey of Multiple Sclerosis Patients, a Report from Isfahan Province, Iran.
|
Dastjerdi, Roshanak Mehdipour |
|
|
59 |
C |
p. |
artikel |
53 |
Health-related quality of life in neuromyelitis optica spectrum disorder patients in an Argentinean cohort
|
Carnero Contentti, Edgar |
|
|
59 |
C |
p. |
artikel |
54 |
High or increasing serum NfL is predictive of impending multiple sclerosis relapses
|
Thebault, Simon |
|
|
59 |
C |
p. |
artikel |
55 |
Humoral and cellular immune responses to SARS CoV-2 vaccination in People with Multiple Sclerosis and NMOSD patients receiving immunomodulatory treatments
|
Bock, H. |
|
|
59 |
C |
p. |
artikel |
56 |
Humoral and cellular immunity in convalescent and vaccinated COVID-19 people with multiple sclerosis: Effects of disease modifying therapies
|
Habek, Mario |
|
|
59 |
C |
p. |
artikel |
57 |
Humoral Immune Response to SARS-CoV-2 Vaccination in MS Patients
|
Oreja-Guevara, Celia |
|
|
59 |
C |
p. |
artikel |
58 |
Hypogonadism in men with multiple sclerosis: Prevalence and clinical associations
|
Diaconu, Claudiu |
|
|
59 |
C |
p. |
artikel |
59 |
Identification of miRNAs and their potential effects on multiple sclerosis related pathways using ın silico analysis
|
Erkal, Burcin |
|
|
59 |
C |
p. |
artikel |
60 |
Identification of multiple sclerosis-related genes regulated by EBV-encoded microRNAs in B cells
|
Rang, Xinming |
|
|
59 |
C |
p. |
artikel |
61 |
Impact of Gender on Multiple Sclerosis Natural History: Findings from a Tunisian Cohort
|
Kacem, Imen |
|
|
59 |
C |
p. |
artikel |
62 |
Implications of Low-Titer MOG Antibodies
|
Levy, Michael |
|
|
59 |
C |
p. |
artikel |
63 |
Improvement of gait and balance in patients with multiple sclerosis after multidisciplinary physical rehabilitation: Analysis of real-world data in Russia
|
Stepanova, A. |
|
|
59 |
C |
p. |
artikel |
64 |
Improvements in Quality of Life at 1 Year in Patients Treated with Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: An Interim Analysis of Clarify-MS
|
Solari, Alessandra |
|
|
59 |
C |
p. |
artikel |
65 |
Incidence of cancer in patients with multiple sclerosis (MS) who were treated with fingolimod: A systematic review and meta-analysis
|
Askari, Mozhde |
|
|
59 |
C |
p. |
artikel |
66 |
Incidence, prevalence, and characteristics of heart failure among patients with multiple sclerosis: A systematic review and meta-analysis
|
Bagherieh, Sara |
|
|
59 |
C |
p. |
artikel |
67 |
Incidence, Severity, Outcomes, and Risk Factors of COVID-19 in Multiple Sclerosis: An Observational Study in the Middle East
|
Alroughani, Raed |
|
|
59 |
C |
p. |
artikel |
68 |
Inform Interferon Beta Exposure in the 2nd and 3rd Trimester of Pregnancy: A Register-Based Drug Utilisation Study in Finland and Sweden
|
Espin, Meritxell Sabidó |
|
|
59 |
C |
p. |
artikel |
69 |
Initial Clinical and Neuroradiological Features at Presentation of Patients with Multiple Sclerosis: A Hospital-Based Experience from Oman
|
Al-Asmi, Abdullah |
|
|
59 |
C |
p. |
artikel |
70 |
Intranasal administration of fingolimod (FTY720) attenuates demyelination area in lysolecithin-induced demyelination model of rat optic chiasm
|
Ghasemi-Kasman, Maryam |
|
|
59 |
C |
p. |
artikel |
71 |
Irregular degree centrality in neuromyelitis optica spectrum disorder patients with optic neuritis: A resting-state functional magnetic resonance imaging study
|
Wei, Ruili |
|
|
59 |
C |
p. |
artikel |
72 |
Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic
|
Hradilek, Pavel |
|
|
59 |
C |
p. |
artikel |
73 |
Lennox-Gastaut Syndrome and MS: Is it a Coincidence?
|
Megherbi, Lilia |
|
|
59 |
C |
p. |
artikel |
74 |
Lifetime physical activity is associated with gut bacteria and brain health in people with multiple sclerosis: Focus on physical activity intensity
|
Mokhtarzade, Motahare |
|
|
59 |
C |
p. |
artikel |
75 |
Long-Term Efficacy for Patients Receiving Cladribine Tablets in CLARITY/CLARITY Extension: Primary Results from 9–15 Years of Follow-Up in the CLASSIC-MS Study
|
Giovannoni, Gavin |
|
|
59 |
C |
p. |
artikel |
76 |
Lower motor neuron involvement in patients with neuromyelitis optica spectrum disorders
|
He, Mianwang |
|
|
59 |
C |
p. |
artikel |
77 |
Low vitamin D levels do not predict risk of autoimmune disease following alemtuzumab treatment for multiple sclerosis
|
Arnett, Simon |
|
|
59 |
C |
p. |
artikel |
78 |
Managing neuropsychological impairment in multiple sclerosis – Controlled study on a standardized metacognitive intervention (MaTiMS)
|
Pöttgen, Jana |
|
|
59 |
C |
p. |
artikel |
79 |
Markers of Epstein-Barr virus and Human Herpesvirus-6 infection and multiple sclerosis clinical progression
|
Tao, Chunrong |
|
|
59 |
C |
p. |
artikel |
80 |
Medical cannabis use in Canadians with multiple sclerosis
|
Santarossa, Talia M |
|
|
59 |
C |
p. |
artikel |
81 |
Medication Adherence Among Patients with Multiple Sclerosis During the COVID-19 Pandemic: Perspective from the Near East Region
|
Al-Naqshbandi, Murad |
|
|
59 |
C |
p. |
artikel |
82 |
MicroRNA-484 and Apoptotic Protease Activating Factor-1 Gene in Relapsing Remitting Multiple Sclerosis: the Possible Interplay
|
Elmazny, Alaa |
|
|
59 |
C |
p. |
artikel |
83 |
MRI Findings in Late-Onset Multiple Sclerosis; a Systematic Review and Meta-Analysis
|
Naseri, Amirreza |
|
|
59 |
C |
p. |
artikel |
84 |
Multiple Sclerosis During Pregnancy: Data from the MS Clinic in Benghazi Medical Center
|
Bennour, Anwaar Mukhtar |
|
|
59 |
C |
p. |
artikel |
85 |
Multiple Sclerosis Performance Test (MSPT): Normative study of 428 healthy participants ages 18 to 89
|
Rao, Stephen M. |
|
|
59 |
C |
p. |
artikel |
86 |
Multiple Sclerosis Specialized Nurses in Saudi Arabia: Challenge, and Opportunities
|
Alarieh, Rola |
|
|
59 |
C |
p. |
artikel |
87 |
Neurofilament Light Chains: A Reliable Biomarker of Disease Activity in MS
|
Ashfaq, Ayesha |
|
|
59 |
C |
p. |
artikel |
88 |
NMOSD: How Long to Treat
|
Chakraborty, Rajarshi |
|
|
59 |
C |
p. |
artikel |
89 |
Patient Reported Outcomes of New Brand-Generic Product of Teriflunomide in Patients with Relapsing-Remitting Multiple Sclerosis: Preliminary Analysis
|
Abolfazli, Roya |
|
|
59 |
C |
p. |
artikel |
90 |
Pediatric neuromyelitis optica spectrum disorders in Portugal: A multicentre retrospective study
|
Martins, Cecília |
|
|
59 |
C |
p. |
artikel |
91 |
Pelvic floor muscle training in multiple sclerosis patients with lower urinary tract dysfunction: A systematic review and meta-analysis
|
Kajbafvala, Mehrnaz |
|
|
59 |
C |
p. |
artikel |
92 |
Perceived stress in multiple sclerosis patients: Relationship with mood states and pain experience
|
Khedr, Mahmoud A. |
|
|
59 |
C |
p. |
artikel |
93 |
Phenotyping the Pediatric Demyelinating Events at the Multiple Sclerosis Center at the American University of Beirut
|
Saab, Georges |
|
|
59 |
C |
p. |
artikel |
94 |
Physical exercise may improve problem-solving skills and emotional intelligence in patients with relapsing-remitting multiple sclerosis: A cross-sectional study
|
Tasci, Irem |
|
|
59 |
C |
p. |
artikel |
95 |
Practical issues concerning the use of Magnetic Resonance Imaging in Multiple Sclerosis in Latin America: Discussion from 16 centres on behalf of the Foro Latam EM Study Group
|
Ciampi, Ethel |
|
|
59 |
C |
p. |
artikel |
96 |
Pregnancy outcomes following maternal or paternal exposure to teriflunomide in the Danish MS population
|
Andersen, Johanna Balslev |
|
|
59 |
C |
p. |
artikel |
97 |
Pregnancy Outcomes in Patients with Multiple Sclerosis Following Exposure to Ofatumumab
|
Yamout, Bassem |
|
|
59 |
C |
p. |
artikel |
98 |
Prevalence of MS in Tehran, Iran in 2020 and Its Forecast for the Next 10 Years
|
Eskandarieh, Sharareh |
|
|
59 |
C |
p. |
artikel |
99 |
Prevalence of Urinary Tract Symptoms in Patients with Multiple Sclerosis and Health Care Seeking Behavior: A Cross Sectional Study in Riyadh, Saudi Arabia.
|
Harbi, Awad Al |
|
|
59 |
C |
p. |
artikel |
100 |
Primary Results of NOVA: A Randomized Controlled Study of the Efficacy of 6 Week Dosing of Natalizumab Versus Continued 4-Week Treatment for Multiple Sclerosis
|
Foley, John |
|
|
59 |
C |
p. |
artikel |
101 |
Psychological impacts of COVID-19 pandemic on individuals living with multiple sclerosis: A rapid systematic review
|
Zarghami, Amin |
|
|
59 |
C |
p. |
artikel |
102 |
Psychotic Symptoms Revealing Multiple Sclerosis: Case Report
|
Bader, Sondes |
|
|
59 |
C |
p. |
artikel |
103 |
Radiologically Isolated Syndrome Conversion to Multiple Sclerosis
|
Sabeti, Fatemeh |
|
|
59 |
C |
p. |
artikel |
104 |
Real-world experience on the use of COVID-19 vaccination in patients with multiple sclerosis treated with Cladribine tablets in the Gulf region
|
Inshasi, Jihad |
|
|
59 |
C |
p. |
artikel |
105 |
Real-World Experience with Cladribine in the MSBase Registry
|
Butzkueven, Helmut |
|
|
59 |
C |
p. |
artikel |
106 |
Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications – A pilot study
|
Moser, Tobias |
|
|
59 |
C |
p. |
artikel |
107 |
Regional (but strategic) assessment for a generalized disorder (Sarcopenia)
|
Razaq, Sarah |
|
|
59 |
C |
p. |
artikel |
108 |
Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis
|
Ciampi, Ethel |
|
|
59 |
C |
p. |
artikel |
109 |
Self-perceived versus physician documented adverse events in patients with multiple sclerosis REGIMS-a pharmacovigilance registry for patients with multiple sclerosis in Germany
|
Moeller, Sarah Noelle |
|
|
59 |
C |
p. |
artikel |
110 |
Serum molecular biomarkers in neuromyelitis optica and multiple sclerosis
|
Fu, Cong-Cong |
|
|
59 |
C |
p. |
artikel |
111 |
Serum Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
|
Hassoun, Hayder K. |
|
|
59 |
C |
p. |
artikel |
112 |
Sleep Disorders in Multiple Sclerosis Patients
|
Bader, Sondes |
|
|
59 |
C |
p. |
artikel |
113 |
Sociodemographic Characteristics of Patients with Multiple Sclerosis Disease in Morocco.
|
Lotfi, Rachid |
|
|
59 |
C |
p. |
artikel |
114 |
S1P receptor modulators in Multiple Sclerosis: Detecting a potential skin cancer safety signal
|
Stamatellos, Vasileios-Periklis |
|
|
59 |
C |
p. |
artikel |
115 |
Systematic review and meta-analysis of Mycobacterium avium subsp. paratuberculosis as environmental trigger of multiple sclerosis
|
Ekundayo, Temitope C. |
|
|
59 |
C |
p. |
artikel |
116 |
Teaching case in MS differential diagnosis: A Longstanding diagnosis of MS with severe disability
|
Solomon, Andrew J. |
|
|
59 |
C |
p. |
artikel |
117 |
Telemedicine and Multiple Sclerosis Management in the Era of COVID-19, Al-Azhar Experience
|
Essmat, Ahmed |
|
|
59 |
C |
p. |
artikel |
118 |
The Effect of Disease Modifying Drugs of Multiple Sclerosis on the Effectiveness of BBIBP-CorV COVID19 Vaccine
|
Ghaffari, Mehran |
|
|
59 |
C |
p. |
artikel |
119 |
The Effect of Rituximab on Mood Disorders in Multiple Sclerosis
|
Poursadeghfard, Maryam |
|
|
59 |
C |
p. |
artikel |
120 |
The Effect of Seasonal Variation on Relapse Rate in Patients with Relapsing-Remitting Multiple Sclerosis in Saudi Arabia
|
Makkawi, Seraj |
|
|
59 |
C |
p. |
artikel |
121 |
The elimination of circulating Epstein-Barr virus infected B cells underlies anti-CD20 monoclonal antibody activity in multiple sclerosis: A hypothesis
|
Berger, Joseph R. |
|
|
59 |
C |
p. |
artikel |
122 |
The Psychological Effect of COVID19 Pandemic on Neuromyelitis Optica Spectrum Disorder Patients and Their Attitude Change After a Year of the Pandemic in Isfahan, Iran.
|
Dastjerdi, Roshanak Mehdipour |
|
|
59 |
C |
p. |
artikel |
123 |
The Relationship Between Smoking and Multiple Sclerosis Severity in Saudi Arabia
|
Makkawi, Seraj |
|
|
59 |
C |
p. |
artikel |
124 |
Thermal dysregulation in patients with multiple sclerosis during SARS-CoV-2 infection. The potential therapeutic role of exercise
|
Razi, Omid |
|
|
59 |
C |
p. |
artikel |
125 |
The Role of Gut Microbiata in Multiple Sclerosis
|
Zahka, Caesar |
|
|
59 |
C |
p. |
artikel |
126 |
To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England
|
Tugemann, Bastian |
|
|
59 |
C |
p. |
artikel |
127 |
Trait mindfulness, emotion dysregulation, and depression in individuals with multiple sclerosis
|
Duraney, Elizabeth Jean |
|
|
59 |
C |
p. |
artikel |
128 |
Trends in administrative prevalence of multiple sclerosis and utilization patterns of disease modifying drugs in Germany
|
Holstiege, Jakob |
|
|
59 |
C |
p. |
artikel |
129 |
Two-dimensional measurements with cut-off values are useful for assessing brain volume, physical disability, and processing speed in multiple sclerosis
|
Nishizawa, Kouichi |
|
|
59 |
C |
p. |
artikel |
130 |
Type of serum collection tube does not impact neurofilament light chain levels
|
Sotirchos, Elias S. |
|
|
59 |
C |
p. |
artikel |
131 |
Uncovering patterns of real-world psychological support seeking and the patient experience in multiple sclerosis
|
Morris-Bankole, Hannah |
|
|
59 |
C |
p. |
artikel |
132 |
Urine neopterin in childhood acute demyelinating diseases: Potential for differential diagnosis
|
Kayaoğlu, Meltem Yıldız |
|
|
59 |
C |
p. |
artikel |
133 |
Using myelin water imaging to link underlying pathology to clinical function in multiple sclerosis: A scoping review
|
Edwards, Erin M. |
|
|
59 |
C |
p. |
artikel |
134 |
Validation of the Norma Latina neuropsychological assessment battery in individuals with multiple sclerosis in Mexico
|
Rivera, Diego |
|
|
59 |
C |
p. |
artikel |
135 |
Variability of objective gait measures across the expanded disability status scale in people living with multiple sclerosis: A cross-sectional retrospective analysis
|
Zanotto, Tobia |
|
|
59 |
C |
p. |
artikel |
136 |
Variables Affecting Disease Modifying Therapy Adherence and Impact of Adherence on Multiple Sclerosis Patients (Egyptian Experience)
|
Abdelsalam, Amr |
|
|
59 |
C |
p. |
artikel |
137 |
Vitamin D3 Improves Behavioral Dysfunction and Promotes Remyelination in Multiple Sclerosis Model Induced by Cuprizone
|
Al-Otaibi, Kholoud M. |
|
|
59 |
C |
p. |
artikel |
138 |
Water-Pipe and Cigarette Smoking, Drug Abuse and Alcohol Consumption and the Risk of Primary Progressive Multiple Sclerosis: A Population Based Case-Control Study
|
Eskandarieh, Sharareh |
|
|
59 |
C |
p. |
artikel |
139 |
Wilcoxon-Mann-Whitney odds ratio: A statistical measure for ordinal outcomes such as EDSS
|
Howard, C.W. |
|
|
59 |
C |
p. |
artikel |